Real World Drug-Eluting Stent Prospective, Open, Multi-site, Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent By SMart Angioplastry Research Team (SMARTDESK-MX)
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2018
At a glance
- Drugs Sirolimus (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms SMARTDESK-MX
- 07 Feb 2018 Planned End Date changed from 1 Jun 2020 to 31 Jan 2021.
- 07 Feb 2018 Planned primary completion date changed from 1 Dec 2018 to 31 Jan 2019.
- 12 Dec 2016 New trial record